BROOMFIELD, Colo., April 12, 2011 /PRNewswire/ — Lanx®,
Inc., a privately held medical device company focused on developing
and commercializing innovative devices for spinal surgery, today
announced the initial launch of its Durango™ Stand-Alone ALIF
System (Durango), following 510(k) clearance in February. The
announcement was made at the 2011 American Association of
Neurological Surgeons (AANS) Annual Meeting, Denver, CO.
The Durango system is intended to treat degenerative disc
disease at one or two levels from L2 to S1 through anterior lumbar
interbody fusion (ALIF), and has been approved as a stand-alone
implant when used with all four fixation screws. It is the first
system on the market to offer multiple plate options, including a
full plate, a zero-profile plate, and the first ever half plate
with 15 degree angled screws for more challenging anatomies.
“The Durango system expands the breadth of our fusion portfolio,
offering a reliable, integrated ALIF solution to meet the needs and
preferences of surgeons and improve care for diverse patient
anatomies,” said Dan Gladney, Chief Executive Officer, Lanx.
“After several successful cases, the new anchored cage
continues to receive positive feedback regarding the versatility of
its plate options and the system’s ease of implantation.”
The Durango system has been designed to improve stability and
promote fusion, combining a PEEK OPTIMA® LT1 large footprint
interbody spacer, a titanium anterior plate and four fixation
screws. The system also includes a full set of specialized
instrumentation and a one-step cover plate with a secure, center
set screw to prevent screw back-out.
“The thoughtful design of the Durango system, with its variety
of plates and screw angles, is significant in that it allows for a
unique, tailored approach to ALIF based on the affected vertebral
level and patient’s anatomy,” said Randall W. Porter, M.D.,
neurosurgeon at Barrow Neur